Global Multimodal Imaging Market Definition
Multimodal imaging is also known as multiplexed imaging. It refers to the simultaneous production of signals for more than one imaging technique. Multimodal imaging techniques usually use two or more imaging systems in a single examination. In clinics and hospitals, the usage can be commonly seen in PET-SPECT and PET-CT scanners.
Typically, multimodal imaging is used by medical professionals to know the exact localization, extent, and metabolic activity of the target tissue. It is also very useful in yielding the tissue flow and noticing any functional changes within the surrounding tissues, along with highlighting any pathognomonic changes leading that could lead to an eventual disease. The technology used in multimodal imaging is effective for functional imaging that is being used for primary-to-metastatic cancer screening of the body, neuro-assessment of gliomas, integrated stroke imaging exams, and functional neuroimaging exams.
Owing to the advantages of multimodal imaging, the scope of non-invasive exploration of the human body has subsequently grown. Through advanced multimodal imaging, both intra-patient and extra-patient image fusion can be performed. In intra-patient image fusion, a true form of image is developed and requires specially designed equipment that has dedicated instrumentation for each modality. On the other hand, extra-patient involves the fusion of images with the help of mathematical algorithms and computational power. Multimodal imaging aids in extending the exploration by combining detailed anatomy with the function that is captured using various cross-sectional modalities.
Global Multimodal Imaging Market: Key Insights
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~USD 3 Billion |
|
Forecast Year Market Size (2035) |
~USD 5 Billion |
|
Regional Scope |
|
Global Multimodal Imaging Market Size, Forecast, and Trend Highlights Over 2023 - 2035
The global multimodal imaging market is estimated to garner a revenue of ~USD 5 Billion by the end of 2035 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 3 Billion in the year 2022. The market is estimated to grow on the back of the rising level of the geriatric population globally as they are more prone to chronic diseases and the increasing research & development in radiotracer technology along with government support for promoting multimodal imaging research through research grants. According to the World Health Organization data, the global population of people aged 60 and above is expected to increase to 1.4 billion by the end of 2030 and this figure is projected to reach 2.1 billion by 2050.
Multimodal imaging technology helps in the early detection of diseases in fields such as urology and oncology. The global multimodal imaging market is estimated to witness growth on account of its increasing adoption in various applications including urology, cardiology, and neurological surgeries. Moreover, increasing technological advancements in diagnostic imaging modalities are also expected to drive the growth of the global multimodal imaging market in the coming years. Furthermore, the rapid development of software that provides accurate data and interpretation is anticipated to increase the usage of multimodal imaging for diagnosis, identification of diseases, improve treatment processes, and enhance patient monitoring. Moreover, multimodal imaging has been highly used by surgeons owing to the recent technological advancements and increased preference for minimally invasive medical procedures along with the early need treatment intervention. In addition, the usage of different types of multimodal imaging techniques such as PET/CT, MR/CT, SPECT/CT, and CT/CT is anticipated to generate revenue for the market as multimodal imaging helps locate disease and anatomically guide the surgeon and aid patients to receive better treatment.
Global Multimodal Imaging Market: Growth Drivers and Challenges
Growth Drivers
-
Increasing Cases of Cancer Globally – Multimodal imaging technology are effective in the detection of tumor lesions in the human body. With the growing cases of cancer among the global population, the multimodal imaging market is expected to boost in the forecast period. According to data from the Centers for Disease Control and Prevention, there were approximately 1,752,735 new cancer cases in the United States in 2019.
-
Rise in Prevalence of Rare Diseases – With the population shifting towards an unhealthy lifestyle, rare diseases are being discovered every day. Proper detection, diagnosis, and treatment of such diseases require advanced medical products such as multimodal imaging. Thus, the rise in the prevalence of rare diseases is anticipated to bring lucrative growth opportunities for market growth in the analysis period. For instance, all over the world, around 300 million people are living with a rare disease and it affects nearly 4% to 6% of the total world population.
-
High Expenditure in the Research & Development Sector – As per data from World Bank, global research and development expenditure in proportion to gross domestic product (GDP) was around 2.63% in 2020, up from 2.2% in 2018.
-
Growth of Healthcare Expenditure – Major key players and government are focused on developing novel multimodal imaging systems for proper diagnosis and treatment. Thus, companies have been investing in the research & development sector to introduce technological advanced multimodal imaging products in the healthcare industry. According to recent data, in 2020 total healthcare expenditure was about ~USD 4 trillion, about 19% of the GDP of the United States.
-
Increasing Growth of the Biotechnology Industry – For instance, the Indian biotechnology industry is projected to reach ~USD 145 billion by the end of 2025.
Challenges
- High Cost of Multimodal Imaging Systems and Availability of Substitute – The use of multimodal imaging methods for defining the extent of spread and the hemodynamic impact, timely diagnosis, and monitoring responses is becoming common in the treatment of malignant cardiac tumors. Yet, the availability of other alternatives such as biopsy analysis which is warranted by many healthcare practitioners to obtain an accurate histologic diagnosis in cases of suspected malignant cardiac tumors is expected to lower the adoption rate of multimodal imaging in the upcoming years. Also, the high costs associated with it are estimated to hinder market growth during the forecast period.
- Dearth of Skilled Professionals
- Stringent Rules and Regulation Are Hindering Clinical Multimodal Imaging Technologies
Global Multimodal Imaging Market Segmentation
The global multimodal imaging market is segmented and analyzed for demand and supply by end-user in hospitals, diagnostic imaging centers, and others. Out of these segments, the hospital segment is anticipated to garner the largest market share by the end of 2035, backed by the rising number of hospitals globally along with the increasing growth of the hospital industry. According to the data, the total number of hospitals in the United States in 2020 was about 6,000 and the number of hospitals in Japan in the same year was about 8,100. Furthermore, multimodal imaging is mostly present in hospital settings by medical professionals which makes it the first choice for patients suffering from diseases for proper treatment. Also, the development of multimodal imaging devices in hospitals along with the presence of various imaging technologies including hyperpolarized MRS, PET, and molecular ultrasound imaging is expected to support revenue growth of this segment.
The global multimodal imaging market is also segmented and analyzed for demand and supply by application into brain & neurology, cardiology, oncology, ophthalmology, and others. Out of these, the cardiology segment is attributed to holding a significant share during the assessment period. Various features of multimodal imaging which include echocardiography, cardiac computed tomography (CCT), cardiac magnetic resonance (CMR), and nuclear cardiology have helped doctors to understand and perform the treatment of cardiovascular disease. This trend is anticipated to contribute positively to segment growth. Multimodal imaging has also helped in performing noninvasive procedures on patients suffering from coronary artery disease, structural heart disease, arrhythmia, and heart failure. Multimodal imaging techniques have efficiently assisted patients in cardiovascular diagnostics. This factor is projected to drive segment growth to a significant extent.
Our in-depth analysis of the global multimodal imaging market includes the following segments:
|
By Product |
|
|
By Technology |
|
|
By Application |
|
|
By End User |
|
Global Multimodal Imaging Market Regional Synopsis
The North America multimodal imaging market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. This can be accredited to the rising prevalence of cardiovascular diseases, the adoption of multimodal imaging systems in cardiology, and increasing healthcare expenditure in the region. According to statistics, about 695,000 patients die from heart disease every year in the United States. In addition, approximately 804,000 US citizens suffer a heart attack each year. Also, the presence of a strong healthcare network in the region, the availability of major market players along with their innovative product launches, massive investments for the development of advanced imaging systems, and growing adoption of technologically developed medical imaging and visualization systems are anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of imaging products are also anticipated to boost market growth during the forecast period.
Top Featured Companies Dominating the Global Multimodal Imaging Market
- United Imaging Healthcare Co., Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- General Electric Company
- Siemens Healthcare GmbH
- Mediso Ltd.
- Neusoft Medical Systems Co., Ltd.
- Infraredx (Nipro)
- Spectrum Dynamics Medical
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Topcon Corporation
